Addition, an existing investor, led the round with participation by Tiger Global, ACME Capital, Declaration Capital, Fifth Wall Ventures, and Redesign Health, all of whom are current investors. Imaginary Ventures also participated in this round as a new investor. The funding will be used to support national expansion, further advancements in technology, and the acceleration of a proprietary education program for providers. Ever/Body's Series C funding brings the company's total capital raised to over $100M since its launch in September 2019.

Ever/Body opened its first location in New York City in 2019, pioneering a first-of-its-kind approach to cosmetic dermatology that combines an unparalleled industry standard of medical expertise with a convenient and modern client experience. Ever/Body leverages its proprietary technology platform to create a seamless and personalized client journey, from appointment scheduling to pre- and post-treatment care. Ever/Body is also leading the category with its best-in-class provider education program, which ensures that providers are able to treat a diverse range of clientele, including all ages, skin tones, body types, and genders. The company, part of the Redesign Health portfolio, is led by CEO Amy Shecter and features a predominantly female leadership team.